SequelSEC

Catheter Precision, Inc. VTAK

Surgical & Medical Instruments & Apparatus · CIK 0001716621 · Fiscal year ends 1231

Revenue
$1.92M
Fiscal year ended 2026-06-30
Operating income
-$19.16M
Fiscal year ended 2026-06-30
Free cash flow
-$9.37M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$3.90MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$1.45Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue4.8×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.6×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio0.10x2th
Gross margin92.3%96th
Operating margin-2581.6%7th
Net margin-2098.0%7th
FCF margin-1015.0%9th
Revenue YoY growth95.0%90th
SBC / revenue41.3%84th
CapEx / revenue2.1%43th

Catheter Precision, Inc. (VTAK) reported revenue of $1.92M and net income of -$13.00M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Catheter Precision, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Catheter Precision, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$1.92M
Cost of revenue$1.00M
Gross profit$914.00K
Operating income-$19.16M
Net income-$13.00M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$13.81M
Income tax expense-$623.00K
Diluted EPSUnavailable
Selling, general & administrative$12.18M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Catheter Precision, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$643.00K
Total assets$36.87M
Current assets$2.51M
Total liabilities$19.73M
Current liabilities$13.45M
Total equity incl. NCI$17.14M
Temporary (mezzanine) equityUnavailable
Inventory$88.00K
Accounts receivable$120.00K
Goodwill$12.96M
Long-term debtUnavailable
Accounts payable$1.45M

Cash flow

Catheter Precision, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$9.35M
Capital expenditures$21.00K
Investing cash flow-$1.96M
Financing cash flow$11.12M
Net change in cash-$195.00K
Stock-based compensation$479.00K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$1.89M

Derived

Catheter Precision, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$9.37M
Gross margin47.7%
Operating margin-1000.3%
FCF margin-489.5%
SBC / revenue25.0%
Current ratio0.19x
Revenue YoY growth219.2%
Net margin-679.1%
R&D / revenueUnavailable
CapEx / revenue1.1%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open VTAK in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-18View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-11View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.